Wave Life Sciences Ltd.WVENASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 96% recommend buying.

Consensus Rating

Buy

24 analysts·High coverage

96%

Rating Distribution

Strong Buy

14%

Buy

2292%

Hold

14%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 135% higher.

Bear Case

$26.00

+90%

Consensus

$32.15

+135%

Bull Case

$50.00

+265%

Price Range24 analysts

Low

Consensus

High

$26.00

$50.00

Current Target

Current Price

$13.70

Upside to Target

$18.45

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-1.22(11 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+116.17%

EPS—

FY2028

Rev+69.21%

EPS—

FY2029

Rev+123.97%

EPS—

Earnings Surprises

Beat rate:33%(4/12 quarters)

Avg surprise:-28.6%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 3, 2026Canaccord Genuity

Wave Life Sciences price target raised to $43 from $40 at Canaccord

Target:$43.00

+220.2%from $13.43

Feb 2, 2026Raymond James

Raymond James: 'WVE regains full economic rights to WVE-006 from GSK'

Target:$26.00

+93.6%from $13.43

Dec 19, 2025H.C. Wainwright

Wave Life Sciences price target raised to $30 from $22 at H.C. Wainwright

Target:$30.00

+81.1%from $16.57

Dec 16, 2025UBS

Wave Life Sciences price target raised to $32 from $24 at Oppenheimer

Target:$32.00

+98.6%from $16.11

Dec 16, 2025Oppenheimer

WAVE Life Sciences (WVE) PT Raised to $32 at Oppenheimer

Target:$32.00

+88.5%from $16.98

Dec 15, 2025Truist Financial

Wave Life Sciences price target raised to $50 from $36 at Truist

Target:$50.00

+201.0%from $16.61

Dec 12, 2025Wedbush

Wedbush raises price target on Wave Life Sciences, adds to Best Ideas List

Target:$33.00

+97.1%from $16.74

Dec 9, 2025Cantor Fitzgerald

Wave Life Sciences price target raised to $34 from $12 at Cantor Fitzgerald

Target:$34.00

+76.4%from $19.27

Dec 9, 2025Wells Fargo

Wave Life Sciences price target raised to $29 from $16 at Wells Fargo

Target:$29.00

+56.6%from $18.52

Dec 9, 2025UBS

Wave Life Sciences price target raised to $30 from $16 at Citi

Target:$30.00

+62.0%from $18.52

Dec 8, 2025RBC Capital

Wave Life Sciences upgraded to Outperform from Sector Perform at RBC Capital

Target:$27.00

+45.8%from $18.52

Dec 8, 2025Raymond James

Wave Life Sciences price target raised to $21 from $14 at Raymond James

Target:$21.00

+13.4%from $18.52

Dec 8, 2025Canaccord Genuity

Wave Life Sciences price target raised to $40 from $19 at Canaccord

Target:$40.00

+116.0%from $18.52

Dec 8, 2025Seaport Global

WAVE Life Sciences (WVE) PT Raised to $28 at Leerink Partners

Target:$28.00

+51.2%from $18.52

Dec 8, 2025Morgan Stanley

WAVE Life Sciences (WVE) PT Raised to $28 at Leerink Partners

Target:$28.00

+51.2%from $18.52

Oct 27, 2025Cantor Fitzgerald

WAVE Life Sciences (WVE) Can Show Fat Mass Loss- Cantor Fitzgerald

Target:$12.00

+68.3%from $7.13

Sep 4, 2025Wells Fargo

Wave Life Sciences price target lowered to $18 from $21 at Wells Fargo

Target:$18.00

+125.0%from $8.00

Sep 3, 2025Leerink Partners

Wave Life Sciences price target raised to $26 from $24 at Leerink

Target:$26.00

+225.0%from $8.00

Nov 12, 2024Truist Financial

WAVE Life Sciences (WVE) PT Raised to $36 at Truist Securities

Target:$36.00

+166.9%from $13.49

Oct 21, 2024RBC Capital

WAVE Life Sciences (WVE) PT Raised to $15 at RBC Capital

Target:$15.00

+1.4%from $14.80

Oct 17, 2024Wells Fargo

Wave Life Sciences price target raised to $22 from $11 at Wells Fargo

Target:$22.00

+47.7%from $14.90

Oct 16, 2024Raymond James

Wave Life Sciences upgraded to Strong Buy from Outperform at Raymond James

Target:$22.00

+48.5%from $14.81

Oct 16, 2024Leerink Partners

Wave Life Sciences price target raised to $22 from $20 at Leerink

Target:$22.00

+46.2%from $15.05

Oct 3, 2024B.Riley Financial

WAVE Life Sciences (WVE) PT Raised to $19 at B.Riley

Target:$19.00

+119.7%from $8.65

Sep 25, 2024Mizuho Securities

Mizuho Reiterates Outperform Rating on WAVE Life Sciences (WVE)

Target:$19.00

+132.0%from $8.19

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance